Beneficial effects of antiepileptic medication on absence seizures and cognitive functioning in children

A Sirén1, A Kylliäinen, M Tenhunen

  • 1Department of Paediatrics, Tampere University Hospital, Tampere, Finland. auli.siren@uta.fi

Insights

Treating absence seizures in children with antiepileptic medication improved their cognitive functions, including attention and memory. Seizure cessation positively impacts neurocognitive development in pediatric epilepsy patients.

Area of Science:

  • Neurology
  • Pediatric Neurology
  • Neuropsychology

Background:

  • Childhood absence epilepsy (CAE) and juvenile absence epilepsy (JAE) are characterized by absence seizures and epileptiform EEG discharges.
  • These neurological conditions can impact cognitive functioning in affected children.

Purpose of the Study:

  • To evaluate the effects of absence seizures and epileptiform EEG discharges on cognitive functioning.
  • To assess the impact of antiepileptic medication in abolishing these seizures and improving cognitive outcomes in newly diagnosed pediatric patients.

Main Methods:

  • Prospective clinical study involving 11 children with CAE/JAE and 10 age/gender-matched controls with mild asthma.
  • Combined video/EEG and neurocognitive assessments (IQ, fine-motor fluency, attention, visual/spatial memory) before and after antiepileptic medication initiation.

Main Results:

  • Children with absence epilepsy showed significant improvements in attention, fine-motor fluency, and visual memory after becoming seizure-free.
  • Control group showed minor improvements in attention and fine-motor skills.
  • Duration of generalized 3-Hz spike-wave discharges and seizures negatively correlated with visual memory performance.

Conclusions:

  • Cessation of absence seizures through antiepileptic medication can support and enhance neurocognitive functioning in children.
  • Early diagnosis and treatment are crucial for mitigating cognitive deficits associated with absence epilepsy.

Related Concept Videos

Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...